ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

May 22, 2009

New Model For Risk Assessment Includes Alcohol, Exercise, Weight

July 29, 2011

In Brief: Senate Markup adds $22 Mil. To NCI Budget; Roper formally Named NCI Deputy Director

September 22, 1989

NCI To Implement Recommendations, Sondik Says

September 2, 1988

Reagan Family History Shows String Risk Factor

August 2, 1985

Niederhuber Outlines NCI Grant Funding Policies for FY08.

February 8, 2008